Elderly Completed Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0031327 (Elderly)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00284336Caelyx Adjuvant in Elderly Breast CancerTreatment